Loading...
XJPX6095
Market cap60mUSD
Jan 17, Last price  
436.00JPY
1D
-0.46%
1Q
-22.56%
Jan 2017
88.34%
IPO
-46.83%
Name

MedPeer Inc

Chart & Performance

D1W1MN
XJPX:6095 chart
P/E
6.39
P/S
0.63
EPS
68.22
Div Yield, %
1.03%
Shrs. gr., 5y
1.76%
Rev. gr., 5y
37.46%
Revenues
14.95b
+2.80%
574,739,000958,320,0001,039,896,000973,648,0001,559,024,0002,199,164,0003,045,538,0005,311,071,0007,435,418,0008,452,113,00014,540,835,00014,948,380,000
Net income
1.48b
+139.89%
113,616,000150,604,00070,397,00023,611,000-363,270,000206,332,000394,850,000725,970,0001,293,475,000812,388,000617,679,0001,481,764,000
CFO
1.89b
+215.07%
27,836,000211,789,00089,783,0004,407,000179,295,000344,025,000374,377,000930,297,0001,361,468,000853,232,000600,073,0001,890,649,000
Dividend
Sep 27, 20244.5 JPY/sh

Profile

MedPeer,Inc. provides services for doctors in Japan. The company operates and manages a web platform for doctors and medical students under the MedPeer name. It also provides online case consultation services; content services that allow to learn clinical knowledge that is useful to doctors in a quiz format; drug evaluation bulletin boards; and online lectures on clinical practices. In addition, the company operates an on-demand video channel centered on medical information under the name MedPeer Channel; MedPeer CAREER, a doctor-specialized recruiting information portal site; MedPeer CLINIC SUPPORT, a portal to check for properties related to opening clinics. The company was incorporated in 2004 and is based in Tokyo, Japan.
URL
https://medpeer.co.jp
IPO date
Jun 27, 2014
Employees
373
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑092015‑09
Income
Revenues
14,948,380
2.80%
14,540,835
72.04%
8,452,113
13.67%
Cost of revenue
8,076,634
8,629,181
4,343,336
Unusual Expense (Income)
NOPBT
6,871,746
5,911,654
4,108,777
NOPBT Margin
45.97%
40.66%
48.61%
Operating Taxes
871,916
408,226
299,036
Tax Rate
12.69%
6.91%
7.28%
NOPAT
5,999,830
5,503,428
3,809,741
Net income
1,481,764
139.89%
617,679
-23.97%
812,388
-37.19%
Dividends
(97,351)
Dividend yield
0.80%
Proceeds from repurchase of equity
(38)
37,915
15,802
BB yield
0.00%
-0.17%
-0.05%
Debt
Debt current
534,976
622,526
112,090
Long-term debt
2,625,072
3,188,122
70,188
Deferred revenue
Other long-term liabilities
187,261
148,651
82,281
Net debt
(4,119,961)
(1,904,540)
(6,222,492)
Cash flow
Cash from operating activities
1,890,649
600,073
853,232
CAPEX
(213,987)
(39,000)
(162,223)
Cash from investing activities
1,266,124
(5,011,980)
(422,885)
Cash from financing activities
(1,269,931)
3,666,316
7,079
FCF
6,104,827
3,613,354
3,649,639
Balance
Cash
7,280,009
5,393,167
6,138,758
Long term investments
322,021
266,012
Excess cash
6,532,590
4,988,146
5,982,164
Stockholders' equity
7,495,379
6,390,824
5,558,862
Invested Capital
6,266,070
7,557,086
2,461,665
ROIC
86.81%
109.86%
167.09%
ROCE
50.80%
44.35%
50.86%
EV
Common stock shares outstanding
21,720
22,070
22,704
Price
562.00
-44.85%
1,019.00
-21.19%
1,293.00
-66.33%
Market cap
12,206,644
-45.72%
22,489,613
-23.39%
29,355,684
-66.76%
EV
8,086,683
20,879,444
23,405,508
EBITDA
7,497,597
6,723,102
4,294,562
EV/EBITDA
1.08
3.11
5.45
Interest
14,395
13,328
1,087
Interest/NOPBT
0.21%
0.23%
0.03%